83 related articles for article (PubMed ID: 16364212)
1. Toosendanin interferes with pore formation of botulinum toxin type A in PC12 cell membrane.
Li MF; Shi YL
Acta Pharmacol Sin; 2006 Jan; 27(1):66-70. PubMed ID: 16364212
[TBL] [Abstract][Full Text] [Related]
2. Cure of experimental botulism and antibotulismic effect of toosendanin.
Shi YL; Wang ZF
Acta Pharmacol Sin; 2004 Jun; 25(6):839-48. PubMed ID: 15169642
[TBL] [Abstract][Full Text] [Related]
3. Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicine.
Shi YL; Li MF
Prog Neurobiol; 2007 May; 82(1):1-10. PubMed ID: 17363132
[TBL] [Abstract][Full Text] [Related]
4. [Biological effects of toosendanin, an active ingredient of herbal vermifuge in Chinese traditional medicine].
Shi YL; Wang WP
Sheng Li Xue Bao; 2006 Oct; 58(5):397-406. PubMed ID: 17041722
[TBL] [Abstract][Full Text] [Related]
5. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel.
Koriazova LK; Montal M
Nat Struct Biol; 2003 Jan; 10(1):13-8. PubMed ID: 12459720
[TBL] [Abstract][Full Text] [Related]
6. The long-term effect of toosendanin on current through nifedipine-sensitive Ca2+ channels in NG108-15 cells.
Li MF; Shi YL
Toxicon; 2005 Jan; 45(1):53-60. PubMed ID: 15581683
[TBL] [Abstract][Full Text] [Related]
7. Toosendanin, a triterpenoid derivative, increases Ca2+ current in NG108-15 cells via L-type channels.
Li MF; Wu Y; Wang ZF; Shi YL
Neurosci Res; 2004 Jun; 49(2):197-203. PubMed ID: 15140562
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of botulinum toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin.
Zhou JY; Wang ZF; Ren XM; Tang MZ; Shi YL
FEBS Lett; 2003 Dec; 555(2):375-9. PubMed ID: 14644446
[TBL] [Abstract][Full Text] [Related]
9. [The binding sites of 3H-toosendanin in rat cerebral cortex homogenate].
Shen GG; Zhuo XL; Shi YL
Sheng Li Xue Bao; 1994 Dec; 46(6):546-52. PubMed ID: 7878482
[TBL] [Abstract][Full Text] [Related]
10. Qualitative and quantitative analysis of toosendanin in Melia toosendan Sieb. Et Zucc (Meliaceae) with liquid chromatography/tandem mass spectrometry.
Ong ES; Ong CN
Rapid Commun Mass Spectrom; 2007; 21(4):589-98. PubMed ID: 17262897
[TBL] [Abstract][Full Text] [Related]
11. Vitamin B2-mediated cellular photoinhibition of botulinum neurotoxin A.
Eubanks LM; Dickerson TJ; Janda KD
FEBS Lett; 2005 Oct; 579(24):5361-4. PubMed ID: 16198354
[TBL] [Abstract][Full Text] [Related]
12. Disulfide bond reduction corresponds to dimerization and hydrophobi-city changes of Clostridium botulinum type A neurotoxin.
Wey JJ; Tang SS; Wu TY
Acta Pharmacol Sin; 2006 Sep; 27(9):1238-46. PubMed ID: 16923346
[TBL] [Abstract][Full Text] [Related]
13. Roles of reactive oxygen species and MAP kinases in the primary rat hepatocytes death induced by toosendanin.
Zhang Y; Qi X; Gong L; Li Y; Liu L; Xue X; Xiao Y; Wu X; Ren J
Toxicology; 2008 Jul; 249(1):62-8. PubMed ID: 18499325
[TBL] [Abstract][Full Text] [Related]
14. Gating and permeability of ion channels produced by botulinum toxin types A and E in PC12 cell membranes.
Sheridan RE
Toxicon; 1998 May; 36(5):703-17. PubMed ID: 9655631
[TBL] [Abstract][Full Text] [Related]
15. Differential entry of botulinum neurotoxin A into neuronal and intestinal cells.
Couesnon A; Shimizu T; Popoff MR
Cell Microbiol; 2009 Feb; 11(2):289-308. PubMed ID: 19016790
[TBL] [Abstract][Full Text] [Related]
16. Bimodal modulation of the botulinum neurotoxin protein-conducting channel.
Fischer A; Nakai Y; Eubanks LM; Clancy CM; Tepp WH; Pellett S; Dickerson TJ; Johnson EA; Janda KD; Montal M
Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1330-5. PubMed ID: 19164566
[TBL] [Abstract][Full Text] [Related]
17. Action of toosendanin on the membrane current of mouse motor nerve terminals.
Xu Y; Shi Y
Brain Res; 1993 Dec; 631(1):46-50. PubMed ID: 8298995
[TBL] [Abstract][Full Text] [Related]
18. Modulation of inward rectifier potassium channel by toosendanin, a presynaptic blocker.
Wang ZF; Shi YL
Neurosci Res; 2001 Jul; 40(3):211-5. PubMed ID: 11448512
[TBL] [Abstract][Full Text] [Related]
19. New insights into clostridial neurotoxin-SNARE interactions.
Breidenbach MA; Brunger AT
Trends Mol Med; 2005 Aug; 11(8):377-81. PubMed ID: 16006188
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction.
Kitamura Y; Matsuka Y; Spigelman I; Ishihara Y; Yamamoto Y; Sonoyama W; Kamioka H; Yamashiro T; Kuboki T; Oguma K
Neuroscience; 2009 Apr; 159(4):1422-9. PubMed ID: 19409226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
